Chris Cleary is about to become a key player in psychedelic medicine. He’s a mental health nurse, with a doctorate in nursing, who has been...
Vous n'êtes pas connecté
Chris Cleary is about to become a key player in psychedelic medicine. He’s a mental health nurse, with a doctorate in nursing, who has been tapped by UC Irvine’s Sue & Bill Gross School of Nursing to lead the creation of new classes in the use of traditional psychedelics – psilocybin, MDMA and the like – as part of a regimen to treat depression, PTSD and other mental health woes. Cleary’s task is tricky, in part, because the drugs in question remain classified as Schedule 1 drugs under federal law. That means the drugs are illegal to use or possess, and it sets limits on the ways researchers can use the drugs or finance their tests. That said, Cleary – and UCI – are hardly...
Chris Cleary is about to become a key player in psychedelic medicine. He’s a mental health nurse, with a doctorate in nursing, who has been...
Harry Black, Bloomberg News Artificial intelligence, touted for its potential to transform medicine, led to some doctors losing skills after just a...
Harry Black, Bloomberg News Artificial intelligence, touted for its potential to transform medicine, led to some doctors losing skills after just a...
A newly established Specialist Hospital for the rehabilitation of drug addicts, Minds Medica, has been commissioned in Ondo City, with a pledge...
Dave Asprey’s psychedelic journey spans continents and states of consciousness — from microdosing LSD in LA to sipping ayahuasca with shamans in...
Dave Asprey’s psychedelic journey spans continents and states of consciousness — from microdosing LSD in LA to sipping ayahuasca with shamans in...
MONDAY, Aug. 18, 2025 -- The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain...
The UT Health San Antonio School of Nursing has earned the prestigious Center of Excellence in Nursing Education designation from the National League...
TUESDAY, Aug. 26, 2025 -- High-concentration delta-9-tetrahydrocannabinol (THC) cannabis products are associated with unfavorable mental health...